Skip to content
value.today

IntegenX Inc

Total raised
$49 M
1 round on record
Latest round
$49 M
Oct 2011
First round on record
Oct 2011
Today
Private
No later event on record

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of IntegenX Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2011$49 MNo. 1$10 to $50 million

IntegenX Inc: Raise no. 1, Oct 2011

Investors in this round

16 investors had bought by the notice of Dec 28, 2012: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$49 M of $50 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • David S. Smith · Executive Officer
  • Dennis C. Harris · Executive Officer, Director
  • Stevan Jovanovich · Executive Officer, Director
  • Andre C. Marion · Director
  • Benjamin S. Schapiro · Director
  • David C. Barker · Director
  • James C. Blair · Director
  • James N. Woody, M.D., Ph.D · Director
  • Louis C. Grever · Director
  • Mostafa C. Ronaghi · Director
  • Ronald W. Eastman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stevan Jovanovich, President and CEO. Source: SEC Form D and 2 amendments, newest notice filed Dec 28, 2012. Read the notice at the SEC.

equity, optionsSEC
Jan 2011$21 MIssued in a merger or acquisition$10 to $50 million

IntegenX Inc: Private sale, Jan 2011

Investors in this round

14 investors had bought by the notice of Mar 2, 2011: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $21 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Stevan Jovanovich · Executive Officer, Director
  • Andre C. Marion · Director
  • David C. Barker · Director
  • Dennis C. Harris · Director
  • Dong-Su C. Kim · Director
  • James C. Blair · Director
  • Mostafa C. Ronaghi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Among the total consideration (i) Cash: $10,034,830.66 (ii) Conversion of notes: $5,588,926.37 (iii) Shares of GenVault Preferred Stock: $5,000,001.50”
  • On a merger: “Series B extension and an acquisition by Issuer of GenVault Corporation in exchange for Series B stock pursuant to a Stock Exchange Agreement dated January 31, 2011.”

Signed by Stevan Jovanovich, President and CEO. Source: SEC Form D, newest notice filed Mar 2, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • IntegenX Inc chose not to state its revenue in its newest notice of a funding round (Dec 2012).

    SEC Form D · Dec 2012

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2012

That is all the official record says: IntegenX Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of IntegenX Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 16 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by IntegenX Inc
NameRoleNamed in
David S. SmithExecutive officerDec 2012
Dennis C. HarrisExecutive officerDec 2012
Stevan JovanovichExecutive officerDec 2012
Andre C. MarionDirectorDec 2012
Benjamin S. SchapiroDirectorDec 2012
David C. BarkerDirectorDec 2012
Dennis C. HarrisDirectorDec 2012
James C. BlairDirectorDec 2012
James N. Woody, M.D., Ph.DDirectorDec 2012
Louis C. GreverDirectorDec 2012
Mostafa C. RonaghiDirectorDec 2012
Ronald W. EastmanDirectorDec 2012
Stevan JovanovichDirectorDec 2012
Dong-Su C. KimDirectorNov 2011